Resistell
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $13M
Investors
- 7
About Resistell
Founded in 2018 in Basel, Switzerland, Resistell AG specializes in advanced antibiotic susceptibility testing.5 million on December 20, 2022.Resistell specializes in the development and commercialization of advanced antibiotic susceptibility testing (AST) solutions, focusing on its proprietary nanomotion technology. Their core product, the Phenotech platform, enables ultra-rapid testing of bacterial sensitivity to antibiotics by detecting nanoscale vibrations produced by living bacterial cells. This innovative method significantly reduces the time required for results compared to traditional culture-based antibiograms, shortening it from days to just a few hours. The technology is primarily intended for use in clinical laboratories and hospitals, aiding healthcare providers in identifying effective antibiotics for treating bacterial infections and addressing the critical issue of antibiotic resistance.Resistell's revenue model is based on partnerships and direct sales targeting healthcare institutions such as hospitals and diagnostic laboratories. The company engages in transactions with clients, providing access to its nanomotion technology and AST solutions through outright purchases or subscription-based services. These transactions typically involve deploying the Phenotech platform within clinical settings, allowing users to conduct rapid antibiotic susceptibility tests. The company plans to introduce new products and expand its market presence, specifically targeting healthcare institutions in additional regions by 2024.
Who invested in Resistell
7 investors across 2 rounds
See all investors in Resistell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Resistell
Who invested in Resistell?
Resistell has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resistell raised?
Resistell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Resistell last raise money?
Resistell's most recent round on record is a Series B, in Dec 2022.
What does Resistell do?
Founded in 2018 in Basel, Switzerland, Resistell AG specializes in advanced antibiotic susceptibility testing.
Where is Resistell headquartered?
Resistell is headquartered in Basel, Switzerland.
Which VCs invest in companies like Resistell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Resistell's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Resistell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.